Both IV Push and IV Drip treatments allow for 90-100% vitamin absorption
The FDA approved an even faster acting mealtime insulin aspart (Fiasp) in 2017
Although similarity-based screening methods are reliable, they may miss lead compounds with entirely new mechanisms of action
Additionally, we classify metabolites according to possible categories of therapeutic intervention, and summarize the latest preclinical and clinical data unveiling the roles of intestinal metabolites in the pathophysiology of major diseases of the gastrointestinal tract, including inflammatory bowel disease, irritable bowel syndrome, colorectal cancer, enteric infection, food allergy, coeliac disease, as well as obesity and metabolic syndrome
Frontiers in Endocrinology, 15, 1431292
Repurposing GLP-1 receptor agonists for parkinson's disease: current evidence and future opportunities